baber/WOPTO huggingface dataset:
Patent CA-3031010-A1 (CA)
Inventor: GIERTZ HELGE
IPC: H02J13/00
Filed: 2017-07-24
Abstract: The invention relates to a method for emitting a controller setpoint (54) for at least one power generator (200), particularly a wind turbine (100) or at least one wind park (112), or a cluster controller (18). The method comprises the following steps: receiving (60) a data packet (33) comprising a current setpoint (48) and a plurality of future setpoints (40), via a data input (32); recording (62) the future setpoints (40) of the received data packet (33) in a memory (36); and emitting (64) the current setpoint (48) of the data packet (33) as a controller setpoint (54) via a data output (34). After a predefined period of time in which, once the data packet (33) has been received (60), no other data packet (33) is received, a first of the recorded future setpoints (40) is emitted via the data output (34) as the next controller setpoint (54). The invention further relates to a device for implementing the method, and to a system comprising same.
Patent CA-3034012-A1 (CA)
Title: Assemblage polariseur
Inventor: TOROK PETER Z
IPC: H01P1/04
Filed: 2017-09-06
Abstract: L'invention concerne un assemblage polariseur comprenant des premier et second composants. Le premier composant comprend une première portion de canal s'étendant le long d'un premier axe de composant et ayant une pluralité de premières saillies de verrouillage et/ou de premières ouvertures sur des côtés opposés de la première portion de canal. Le second composant comprend une seconde portion de canal s'étendant le long d'un second axe de composant et ayant une pluralité de secondes saillies de verrouillage et/ou de secondes ouvertures sur des côtés opposés de la seconde portion de canal. Le second composant peut tourner par rapport au premier composant autour d'un axe de rotation commun entre une position pré-assemblée dans laquelle le second axe de composant est décalé angulairement par rapport au premier axe de composant, et une position assemblée dans laquelle les secondes saillies de verrouillage et/ou les secondes ouvertures s'accouplent avec les premières saillies de verrouillage et/ou les premières ouvertures et les première et seconde portions de canal forment un canal qui fonctionne pour polariser les formes d'onde.
Patent CA-3035011-A1 (CA)
Inventor: MEDOFF MARSHALL
IPC: C12P19/02
Filed: 2010-05-18
Abstract: Biomass feedstocks (e.g., plant biomass, animal biomass, and municipal waste biomass) are processed to produce useful products, such as fuels. For example, systems are described that can convert feedstock materials to a sugar solution, which can then be fermented to produce ethanol. Biomass feedstock is saccharifled in a vessel by operation of a jet mixer, the vessel also containing a fluid medium and a saccharifying agent.
Patent CA-3035270-A1 (CA)
Inventor: Naing Juvenal
IPC: B65B3/04
Filed: 2017-09-12
Abstract: The system of the invention involves monitoring and controlling in a sterilizable environment the peeling of a cover from a tub sealed by the cover. The system and associated method employs a platform having a fiducial source locating structure for holding the tub, a cover removal station disposed to engage with the cover and to peel the cover from the tub. The container assembly for holding nested pharmaceutical container parts comprises a bottom, a top lip that provides a horizontal top sealing surface that has a peripheral outline, and sidewalls located between the bottom and the top lip, a peelable container cover consisting of a sheet of flexible material sealed to the sealing surface of the top lip of the rectangular container to seal the contents of the container, and a cover removal fixture on the container cover.
Patent CA-3035528-A1 (CA)
Title: Compositions de cromolyne pour le traitement de la toux chronique due a une fibrose pulmonaire idiopathique
Inventor: GERHART WILLIAM
IPC: A61M16/10
Filed: 2017-08-29
Abstract: L'invention concerne une méthode de traitement de la toux chronique chez un sujet présentant une fibrose pulmonaire idiopathique (FPI)), qui consiste à administrer au sujet au moyen d'un nébuliseur: une composition pharmaceutique comprenant d'environ 2% en poids à environ 6% en poids de cromolyne sodique, et un agent osmotique ionique.
Patent CA-3037540-A1 (CA)
Title: A unitary assembly for an architectural fenestration, providing dynamic solar heat gain control
Inventor: COLSON WENDELL B
IPC: E06B7/08
Filed: 2011-06-07
Abstract: The present disclosure is related to a unitary assembly for an architectural fenestration, providing dynamic solar heat gain control, which (1) provides a track-based frame structure/blind combination in which the blind is self-correcting should the blind material fall outside of the track; (2) provides directional shading, where the assembly provides for dynamically controlling the amount of light allowed to reach the heat storage unit; (3) provides a blind motor without limiter switches and with a quick-release slip-ring; and (4) provides a heat storage unit which is a thermally efficient, transparent and translucent structure, with which gain from sunny winter days is greater than nighttime loss, so as to provide supplemental heat.
Patent CA-3038075-A1 (CA)
Inventor: SAWHNEY AMARPREET S
IPC: A61K9/00
Filed: 2017-09-25
Abstract: Methods of treating an eye for an ocular condition such as placing a composite depot comprising a xerogel with embedded degradable particles into an anterior chamber of an eye to deliver a therapeutic agent. The xerogel is a hydrogel after exposure to intraocular fluid and is degradable. The degradable particles comprise the therapeutic agent and hydrolytically degrade in the anterior chamber to provide a controlled release of the therapeutic agent into the eye. Materials and processes for making depots are provided as well as alternative methods of their use.
Patent CA-3038800-A1 (CA)
Inventor: ZIMMERMAN JOHN
IPC: H01M4/13
Filed: 2016-12-13
Abstract: Disclosed is an electrode material designed to be a dry in place deposit comprising at least one metal chelating polymer; an active material capable of reversibly intercalating lithium ions; a plurality of electrical conductor particles; a binder polymer. The electrode material is formed into a slurry using a non-aqueous solvent. The metal chelating polymer may be a reaction product of a polyphenolic polymer; an aldehyde, a ketone, or mixtures thereof; and an amine. The electrode material slurry is deposited on a current collector and dried to form a positive electrode in a secondary lithium ion battery. The deposited electrode material has high flexibility, adhesion to the current collector, resistance to electrolyte damage, and low electrical resistance. The electrode material forms a superior positive electrode at a relatively low additional cost and with no increase in process complexity.
Patent CA-3038885-A1 (CA)
Inventor: LANDMAN THOMAS
IPC: A61B8/00
Filed: 2017-10-03
Abstract: The invention relates to an electronic system for foetal monitoring, comprising: at least two ultrasound sensors (20) emitting and receiving ultrasound waves either simultaneously, or simultaneously by groups, or sequentially, the ultrasound sensors (20) being provided to be positioned on at least one part of the mother's abdomen in order to cover the moving foetal cardiac structure and to carry out measurements of the foetal heart rate, the distance between two ultrasound sensors (20) is maintained by a link, a control module (21) of the ultrasound sensors (20) comprising control information of the ultrasound waves sent to at least one ultrasound sensor (20), a treatment module (22) of the ultrasound signals in order to continuously estimate the position of the heart, the foetal heart rhythm and the foetal movements of one or more foetuses on the basis of the signal(s) received from the ultrasound sensors (20).
Patent CA-3039479-A1 (CA)
Inventor: POLO MAURIZIO
IPC: A23L33/14
Filed: 2018-05-11
Abstract: The invention concerns a strain of Saccharomyces bayanus subsp. uvarum identified as SERIUS and deposited at the DBVPG with deposit number 36P. The invention further concerns the use of the strain of Saccharomyces bayanus subsp. uvarum identified as SERIUS (DBVPG 36P) as a food inoculate in the production of foods obtained through alcoholic fermentation, and a selection method for yeast strains of the group Saccharomyces adapted to alcoholic fermentation, particularly of grape, consisting of an isolation step for such yeasts from flowers.
Patent CA-3041170-A1 (CA)
Title: Systemes et procedes de stockage
Inventor: CLARKE PAUL
IPC: B65G1/04
Filed: 2017-10-19
Abstract: L'invention concerne un système de stockage où les marchandises sont stockées dans des conteneurs (10) et les conteneurs (10) sont stockés en piles (12). Au-dessus des piles (12) s'étend un réseau en grille de voies sur lesquelles se déplacent des dispositifs de manipulation de charge (30). Les dispositifs de manipulation de charge (30) soulèvent des conteneurs (10) des piles (12) et, puis, les déposent à d'autres emplacements dans les piles ou les déposent au niveau de postes où des marchandises peuvent être prélevées. Les conteneurs (10) peuvent être pourvus d'un ou de plusieurs des services suivants : courant électrique, commande de courant électrique, chauffage, éclairage, réfrigération, moyens de détection, et moyens d'enregistrement de données. La fourniture de ces services dans des conteneurs individuels plutôt que sur l'ensemble du système, confère de la souplesse au stockage tout en réduisant les coûts et l'inefficacité. Les conteneurs (10) lorsqu'ils sont retirés des piles (12) sont électriquement connectés au dispositif de manipulation de charge (30), le courant étant fourni par une alimentation électrique à l'intérieur du dispositif de manipulation de charge (30).
Patent CA-3042581-A1 (CA)
Inventor: LINDEROTH EMMA
IPC: A61K38/17
Filed: 2017-11-01
Abstract: CD47+ disease cells such as cancer cells are treated using a combination of CD47 blockade drug and a proteasome inhibitor. The anti-cancer effect of one drug enhances the 5 anti-cancer effect of the other. Specific combinations include SIRPaFc as CD47 blockade drug, and one of bortezomib, ixazomib and carfilzomib as proteasome inhibitor. These combinations are useful particularly to treat blood cancers including lymphomas, leukemias and myelomas.
Patent CA-3043315-A1 (CA)
Title: Software-defined device interface system and method
Inventor: JACOBS GYSBERT JOHANNES
IPC: G06F21/76
Filed: 2017-09-05
Abstract: The invention relates to a software defined device interface system 10, a software defined device interface, gateway and a method of defining an interface for a device which uses a specific communication protocol for communication purposes. The system 10 includes a microprocessor/processing unit 12.1, 12.2 with a plurality of communication pins and software/firmware. The software/firmware is configured, based on a specific communication protocol which is used by a particular device 30.1-30.4 for communication purposes, to, in runtime, assign/select one or more of the communication pins to form a virtual port to which the particular device 30.1-30.4 can be connected, upon receiving a configuration instruction from a user to implement the specific communication protocol. The software/firmware is further configured to implement the specific communication protocol through the virtual port, to thereby allow for communication between the microprocessor/processing unit 12.1, 12.2 and the device 30.1-30.4, when the device 30.1-30.4 is connected to the pin(s) of the virtual port.
Patent CA-3043971-A1 (CA)
Title: Portable low-field magnetic resonance imaging methods and apparatus
Inventor: POOLE MICHAEL STEPHEN
IPC: G01R33/34
Filed: 2017-11-22
Abstract: According to some aspects, a low-field magnetic resonance imaging system is provided. The low-field magnetic resonance imaging system comprises a magnetics system having a plurality of magnetics components configured to produce magnetic fields for performing magnetic resonance imaging, the magnetics system comprising, a Bo magnet configured to produce a Bo field for the magnetic resonance imaging system at a low-field strength of less than.2 Tesla (T), a plurality of gradient coils configured to, when operated, generate magnetic fields to provide spatial encoding of magnetic resonance signals, and at least one radio frequency coil configured to, when operated, transmit radio frequency signals to a field of view of the magnetic resonance imaging system and to respond to magnetic resonance signals emitted from the field of view, a power system comprising one or more power components configured to provide power to the magnetics system to operate the magnetic resonance imaging system to perform image acquisition, and a power connection configured to connect to a single-phase outlet to receive mains electricity and deliver the mains electricity to the power system to provide power needed to operate the magnetic resonance imaging system. According to some aspects, the power system operates the low-field magnetic resonance imaging system using an average of less than 1.6 kilowatts during image acquisition.
Patent CA-3045608-A1 (CA)
Title: Capteur pour un outil de fond de trou
Inventor: LAASTAD HARALD ODD
IPC: G01N23/083
Filed: 2017-11-30
Abstract: L'invention concerne un appareil capteur pour un outil de fond de trou 12 comportant un capteur 24 pour prendre des mesures de fond de trou; et un support de capteur 26, 28 pour monter le capteur 24 sur l'outil de fond de trou 12. Le support de capteur 26, 28 comprend un actionneur 26 pour déplacer au moins une partie du capteur 24 dans une direction s'étendant selon un axe longitudinal de l'outil de fond de trou 12, de sorte que, lors de l'utilisation, la/les partie(s) mobile(s) du capteur 24 puisse(nt) se déplacer par rapport à l'outil 12 dans une direction s'étendant selon un axe longitudinal d'un trou de forage. L'appareil capteur est conçu pour enregistrer des mesures à partir du capteur au moyen d'un point sur l'outil 12 en tant que référence pour déterminer une profondeur relative entre des mesures sans utiliser un point de référence externe pour obtenir une indication de la profondeur absolue des mesures.
Patent CA-3051020-A1 (CA)
Title: Method for acquiring user information and relevant device
Inventor: GAO YUN
IPC: G06Q10/08
Filed: 2018-01-10
Abstract: Provided is a method for acquiring user information and a relevant device, the method comprising: a first terminal (10) acquiring a waybill identifier and a logistics platform identifier associated with the first terminal (S301); the first terminal (10) invoking a communication module (11) built-in to the first terminal (10), and sending an information acquisition request to a logistics management server (20) through the communication module (11), with the information acquisition request carrying the waybill identifier and the logistics platform identifier (S302); and the first terminal (10) receiving, through the communication module (11), an information reply message sent by the logistics management server (20), with the information reply message carrying user information corresponding to the waybill identifier and the logistics platform identifier (S306). The first terminal (10) is enabled to acquire the user information from the logistics management server (20) according to the built-in communication module (11), and therefore, there is no need to print the user information on a logistics waybill, thereby achieving privacy for user information between different platforms, and thus improving the security thereof.
Patent CA-3051871-A1 (CA)
Title: Improved carbon molecular sieve adsorbent
Inventor: WHITLEY ROGER DEAN
IPC: B01D53/047
Filed: 2019-08-12
Abstract: Disclosed herein are rapid cycle pressure swing adsorption (PSA) process for separating O2 from N2 and/or Ar. The processes use a carbon molecular sieve (CMS) adsorbent having an O2/N2 and/or O2/Ar kinetic selectivity of at least 5 and an O2 adsorption rate (1 /s) of at least 0.2000 as determined by linear driving force model at 1 atma and 86 °F.
Patent CA-3053663-A1 (CA)
Inventor: CAVALERI FRANCO
IPC: A23L33/12
Filed: 2017-05-29
Abstract: Compositions and methods for providing a person with an exogenous and therapeutically effective supply of ketones are disclosed. The compositions may consist essentially of (a) purified butyrate (or esters or propionate salts thereof) and (b) purified beta-hydroxybutyrate (or esters or propionate salts thereof). The compositions may further include other pharmacologically active agents, such as acetyl-L carnitine, R- alpha lipoic acid, green tea extract, vitamins, and various combinations of such agents. The methods include providing a person with an exogenous supply of ketones, by orally administering a pharmacologic composition, which is effective to deliver 2000 - 5000 mg of a short chain fatty acid (e.g., butyrate) and 5000 - 10,000 mg of ketone (e.g., beta- hydroxybutyrate) on a daily basis. In addition, methods for increasing nuclear factor erythroid 2 related factor 2 (Nrf2) levels in a group of cells are disclosed, which involve the administration of the compositions described above to the group of cells.
Patent CA-3054728-A1 (CA)
Inventor: CHABALA JOE
IPC: F04C19/00
Filed: 2018-02-23
Abstract: A method of controlling a liquid ring pump in a pump system includes monitoring a vacuum pressure of the liquid ring pump using a pressure transmitter configured to transmit a vacuum pressure signal to a controller in operative communication with the liquid ring pump. The method also includes maintaining a predetermined vacuum pressure in the liquid ring pump under variable vacuum flow demand within the pump system in response to the vacuum pressure signal by controlling, via instructions from the controller, a parameter of the liquid ring pump based on a comparison of the vacuum pressure signal to the predetermined vacuum pressure by the controller.
Patent CA-3056308-A1 (CA)
Inventor: CHESSARI GIANNI
IPC: C07H19/207
Filed: 2018-03-28
Abstract: The invention provides a combination comprising: (i) a compound of formula (Io) : (Io) or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims; and (ii) a compound which is SGI-110 (SGI-110) or a tautomer or a solvate or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions containing the combinations and medical uses of the combinations.
Patent CA-3056506-A1 (CA)
Inventor: GOUBIER ANNE
IPC: C07K14/55
Filed: 2018-03-13
Abstract: The present disclosure relates to use of an anti-CD25 antibody, not inhibiting IL-2 - CD25 interaction, with enhanced binding to activating Fc gamma Rs that lead to effective depletion of tumor-infiltrating Treg cells and improved control of established tumors. Combination with anti-programmed cell death protein-1 antibodies further improves tumor rejection.
Patent CA-3057721-A1 (CA)
Title: Harvesting tumbler
Inventor: MCKELLAR AARON
IPC: A01D46/02
Filed: 2018-03-08
Abstract: A harvesting tumbler apparatus includes first and second spaced apart grating segment retainers, and a tumbler grating including a plurality of resiliently tensionable grating segments connected to the first and second grating segment retainers. The resiliently tensionable grating segments extend from each of the first and second grating segment retainers in a spaced apart circular arrangement. The tumbler apparatus further includes a tension mechanism configured to apply a sufficient tension force to the resiliently tensionable grating segments to cause the grating to form a cylindrical shape. In illustrative embodiments, the resiliently tensionable grating segments may include flexible cord segments.
Patent CA-3058695-A1 (CA)
Inventor: WELTI GREGOR
IPC: C07C229/26
Filed: 2018-04-24
Abstract: The present invention provides processes for preparing a compound of formula (I) and pharmaceutically acceptable salts thereof, comprising deprotecting a compound of formula (II), wherein each R3 independently represents a tertiary alkyl group, preferably wherein each R3 is tertiary butyl. The invention also provides intermediates useful for preparing compounds of formula (I) and processes for preparing these intermediates. Additionally the invention provides polymorphic forms of the dichloride salt of the compound of formula (I) and their use in the treatment of proliferative disorders.
Patent CA-3059180-A1 (CA)
Inventor: COBB JOSEPH E
IPC: A61K9/28
Filed: 2017-04-06
Abstract: La présente invention concerne d'une manière générale des comprimés de 4-aminopyridine à libération prolongée, qui comprennent un coeur et un enrobage. Les comprimés à libération prolongée de l'invention sont généralement adaptés pour une administration par voie orale une fois par jour pour le traitement de troubles neurologiques.
Patent CA-3061211-A1 (CA)
Title: Method and apparatus for measuring a height of a vehicle
Inventor: CRONA BJORN
IPC: G01B11/03
Filed: 2019-11-11
Abstract: A method of measuring a height (h) of a vehicle (2) on a road (3) comprises recording with a vehicle classification sensor (6) a 3D representation (11) of the vehicle (2) passing the section (5) and recording with a camera (12) a 2D image (15) of at least an upper portion (16) of the vehicle (2) and a background (17); determining an edge profile (12) between the upper portion (16) and the background (17) establishing a fan (24) of rays (25) each extending from the elevated point (PCAM) and through a different one of multiple points (Pi) along the edge profile (22); shifting the 3D representation (11) in the coordinate system (8) in height (z) until it is tangent to said fan (24); and determining said height (h) of the vehicle (2) from the shifted 3D representation (11') in the coordinate system (8). The invention further relates to an apparatus (1) for performing this method.
Patent CA-3066530-A1 (CA)
Title: Steam sterilized catheter assembly
Inventor: UTAS JAN
IPC: A61M25/00
Filed: 2018-06-29
Abstract: A sterilized medical device assembly comprises a medical device (1) having a hydrophilic surface on at least a part thereof, such as a hydrophilic urinary catheter, and a package (3) forming a closed compartment accommodating the medical device. The medical device is arranged in an activated state in the package, with the hydrophilic surface being wetted with a wetting fluid (2). In addition, a small amount of wetting liquid is freely arranged in the closed compartment of the package, and in direct contact with the hydrophilic surface of the medical device. The volume of the wetting liquid corresponds to between 0.01% and 10% of a volume of the closed compartment. The medical device assembly is steam sterilized, and it has been found that the extra small amount of free liquid is very efficient in ensuring a reliable and efficient steam sterilization.
Patent CA-3071562-A1 (CA)
Inventor: GARNER DETRICK DEYON
IPC: E21B23/01
Filed: 2018-10-03
Abstract: Selon des modes de réalisation, la présente invention concerne un clapet de test pour isoler une pression de trou de forage. Le clapet de test comprend un corps s'étendant d'une première extrémité à une seconde extrémité, le corps possédant un alésage s'étendant à travers celui-ci, un diamètre de l'alésage étant plus grand à une première extrémité qu'à la seconde extrémité. Le clapet de test comprend également une rainure formée à proximité de la première extrémité et s'étendant radialement vers l'extérieur à partir de l'alésage et dans le corps. De plus, le clapet de test comprend une broche antirotation positionnée entre la rainure et la seconde extrémité, la broche antirotation s'étendant radialement vers l'extérieur à partir du corps. Le clapet de test comprend en outre un clapet de non-retour positionné dans l'alésage, le clapet de non-retour permettant un écoulement dans une seule direction et étant mobile entre une position ouverte pour permettre l'écoulement et une position fermée pour bloquer l'écoulement.